Transtreams Technology develops video-processing chips and AI hardware for cloud platforms and edge-computing applications.
Qiming Venture Partners
Activity from announced rounds
- Rounds participated in
- 12
- Confirmed lead rounds
- 2 9 roles undisclosed
- New companies
- 10 First participation on record · 2 follow-on
- Funding in participating rounds
- $962.8M 10 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
12 in all activityDevelops oligonucleotide therapeutics targeting chronic hepatitis B
Develops in vivo CAR-T cell therapies for cancer and autoimmune diseases
Develops interventional therapies for pulmonary hypertension and heart failure
Develops extrahepatic RNA-targeting therapeutics
Develops next-generation cell therapies for oncology and immunology
Develops intelligent platform-driven macrocyclic peptide drug discovery
Develops minimally invasive implantable brain-machine interfaces (BMI) for neurological diseases
Develops multimodal foundation models for video generation and AI productivity
Develops next-generation cell therapies for oncology and immunology
Chinese chip developer building compute-in-memory processors and hardware for running AI models on local devices.
Chinese chip developer building compute-in-memory processors and hardware for running AI models on local devices.